Blog Posts

GAO Report Finds HHS Must Do More to Address Drug Shortages, Doesn’t Mention 340B as a Factor

A new Government Accountability Office report recommended that HHS identify and implement ways to formally coordinate activities relating to drug shortages—particularly, with a key position that oversees such actions set to end next month.
The U.S. Department of Health and Human Services (HHS) should identify and implement ways to formally coordinate activities relating to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Merck Exempts Three More States from 340B Restrictions, Novartis Sues Utah Over Contract Pharmacy Access Law

Merck recently announced it would exempt additional states from its 340B contract pharmacy restrictions.
Merck is lifting its 340B contract pharmacy restrictions in three more states that have recently enacted contract pharmacy access laws—while [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: 5th Circuit Appeals in Louisiana, 4th Circuit Appeal in West Virginia 

Key briefs were filed recently in state contract pharmacy litigation in West Virginia and Louisiana.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B INDUSTRY LEADER SPOTLIGHT

Marcus Hill, Manager, Implementations, VHUB at Verity Solutions

Marcus Hill

Q: Where did you grow up?

Houston, TX

Q: Where did you go to college/graduate school?

For undergrad, I graduated from the University of Houston. Later in life I went back to school and got my master’s in clinical practice management from Texas Tech University Health Science Center.

Q: What are your favorites?

Food: Mexican! I could

Read More »

Expert Tip from Ravin Consultants

img
img

TIP: Ensure behavioral health medications are fully integrated into your 340B strategy to maximize patient access and program savings.


Read More »

News Alert

Trump Revives Controversial 340B Rule for Insulin, EpiPens in Sweeping Health Care Executive Order

President Donald Trump issued an April 15 executive order on drug pricing with a controversial 340B requirement for community health centers.
President Donald Trump (R) last night issued a wide-ranging health care executive order that revives a controversial 340B policy from [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Oregon, Oklahoma Advance 340B Contract Pharmacy Access Bills

The Oregon House voted to approve a 340B contract pharmacy access bill on April 14, the same day that Oklahoma lawmakers advanced a similar bill.
State legislators in Oregon and Oklahoma voted yesterday to advance separate bills that would prohibit drugmakers from placing 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AbbVie Sues Three More States Over Newly Enacted 340B Contract Pharmacy Access Laws

AbbVie has filed lawsuits against four of the five states that have enacted 340B contract pharmacy access laws in 2025.
Pharmaceutical giant AbbVie recently filed lawsuits against the states of Nebraska, North Dakota and South Dakota over their newly enacted [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

Don’t Overlook the Importance of an HIN on Your Wholesale Accounts

SPONSORED CONTENT

It’s easy to remember the days before 340B ESP, when setting up of a wholesale account was an easy and streamlined process. The Health Industry Number (HIN) was not something that was discussed very often prior to the manufacturer restrictions. The HIN is

Read More »

HHS Briefs House E&C Committee Staff on Restructuring, Senate HELP Postpones Kennedy Hearing

HHS Secretary Robert F. Kennedy Jr. was tentatively set to testify before the Senate HELP panel April 10 on his department's restructuring, a hearing which was ultimately postponed.
U.S. Department of Health and Human Services (HHS) officials last week briefed the Republican and Democratic staff of a key [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live